Jennifer Laidler

A phase IIa trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastoma

J. Gains, V. V. Moroz, Matthew Aldridge et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 51 citations

Medicine, Oncology, Radiation Oncology +11

BEACON-Immuno: Results of the dinutuximab beta (dB) randomization of the BEACON-Neuroblastoma phase 2 trial—A European Innovative Therapies for Children with Cancer (ITCC–International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOPEN) trial.

Juliet C. Gray, Lucas Moreno, Rebekah Weston et al. · Journal of Clinical Oncology · 2022 · 31 citations

Medicine, Oncology, Pharmacology +15

Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial

Lucas Moreno, Rebekah Weston, Cormac Owens et al. · Journal of Clinical Oncology · 2024 · 23 citations · Full text

Medicine, Oncology, Pharmacotherapy +12